Valued Advisers Trust has taken a significant step in the investment landscape by filing a registration statement for the Slow Capital Growth ETF. This new exchange-traded fund (ETF) aims to provide investors with long-term capital appreciation, reflecting the trust's commitment to expanding its investment offerings.
The filing, submitted on October 29, 2026, indicates a strategic move by Valued Advisers Trust to tap into the growing demand for ETFs. These funds have become increasingly popular among investors seeking diversified investment options with lower fees compared to traditional mutual funds.
Background
Valued Advisers Trust, an investment company based in Cincinnati, Ohio, is focused on providing innovative investment solutions. The trust operates under the Investment Company Act of 1940 and has a Central Index Key (CIK) of 0001437249. Recent filings include a post-effective amendment to their registration statement, indicating ongoing activity in enhancing their investment products.
What the Filing Says
The filing details the establishment of the Slow Capital Growth ETF, which is designed to seek long-term capital appreciation. As part of this registration statement, the trust has outlined the fund's investment objective and the strategies it plans to employ to achieve this goal.
"The investment objective of the Slow Capital Growth ETF is to provide long-term capital appreciation," the filing states.
Impact
This new ETF may significantly affect both current and potential investors looking for diversified investment options. It will also compete with existing ETFs in the market, thereby enhancing the choices available to investors. The filing reflects Valued Advisers Trust's proactive approach to meeting investor demand and adapting to market trends.
What's Next
The filing does not specify what happens next, but it is expected that Valued Advisers Trust will continue to provide updates as they move forward with the launch of the Slow Capital Growth ETF.
Read Next
BNY Mellon Funds Trust Files Annual Report, Showcases Growth
Listed Funds Trust Delays Metals.io Uranium ETF Launch
Equinox Partners Increases Stake in Silvercrest Asset Management
Nexa Resources reports strong Q3 2026 financial results
TFI International reports Q3 2026 financial results
Bambusa Therapeutics grants stock options to director Liang Howard










